The European digital health market is at a pivotal inflection point, with the musculoskeletal (MSK) sector emerging as a primary frontier for innovation and investment. This market is not merely growing; it is undergoing a fundamental transformation, driven by an aging demographic, the increasing prevalence of chronic conditions, and a critical shift towards data-enabled, value-based care. The European Digital MSK market is projected to reach a revenue of US$3.28 Billion by 2

Hinge Health (NYSE: HNGE) has demonstrated a remarkable post-Initial Public Offering (IPO) performance, with its share price surging approximately 56% since its market debut in May 2025. This significant appreciation reflects robust investor confidence, driven by strong financial results and strategic advancements within the digital musculoskeletal (MSK) care market. The company's first quarterly earnings report as a public entity for Q2 2025 showcased substantial revenue

The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health